Detalhe da pesquisa
1.
A new cure model that corrects for increased risk of non-cancer death: analysis of reliability and robustness, and application to real-life data.
BMC Med Res Methodol
; 23(1): 70, 2023 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36966273
2.
Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study.
Lancet Oncol
; 23(12): 1525-1536, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400102
3.
Estimating Country-Specific Incidence Rates of Rare Cancers: Comparative Performance Analysis of Modeling Approaches Using European Cancer Registry Data.
Am J Epidemiol
; 191(3): 487-498, 2022 02 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34718388
4.
Staging childhood cancers in Europe: Application of the Toronto stage principles for neuroblastoma and Wilms tumour. The JARC pilot study.
Pediatr Blood Cancer
; 68(9): e29020, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34114308
5.
Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement.
Endoscopy
; 52(4): 293-304, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32052404
6.
Trends and projections of pleural mesothelioma incidence and mortality in the national priority contaminated sites of Sicily (Southern Italy).
Epidemiol Prev
; 44(4): 218-227, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32921027
7.
Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020.
BMC Cancer
; 18(1): 169, 2018 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29426306
8.
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.
Lancet Oncol
; 18(8): 1022-1039, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28687376
9.
Salmerón et al. Respond to "Future Directions for Predicting Rare Cancer Rates".
Am J Epidemiol
; 191(3): 503-504, 2022 02 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34874996
10.
Mortality in Italian veterans deployed in Bosnia-Herzegovina and Kosovo.
Eur J Public Health
; 26(4): 712-7, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26635013
11.
Is long-term cancer survivors' quality of life comparable to that of the general population? An italian study.
Support Care Cancer
; 23(9): 2663-8, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25646617
12.
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.
Lancet Oncol
; 15(1): 23-34, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24314615
13.
Protocol for investigating data quality and reporting outcomes of pediatric gliomas in population-based cancer registry research.
STAR Protoc
; 5(1): 102905, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38386548
14.
Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002.
Haematologica
; 98(5): 744-52, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23403323
15.
Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study.
Haematologica
; 98(2): 230-8, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22983589
16.
Descriptive epidemiology of the head and neck cancers in old patients.
Front Oncol
; 13: 1102236, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37293589
17.
Prediction of Risk of Metastatic Recurrence for Female Breast Cancer Patients in the Presence of Competing Causes of Death.
Cancer Epidemiol Biomarkers Prev
; 32(12): 1683-1689, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37707367
18.
Cancer prevalence in Italy: an analysis of geographic variability.
Cancer Causes Control
; 23(9): 1497-510, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22821425
19.
Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project.
Blood
; 116(19): 3724-34, 2010 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-20664057
20.
[Health, public health, research, and participation. Considerations on the Italian ''Vaccination decree'']. / Salute, sanità pubblica, ricerca e partecipazione. Considerazioni dopo il "decreto vaccini".
Epidemiol Prev
; 41(3-4): 149-151, 2017.
Artigo
em Italiano
| MEDLINE | ID: mdl-28929702